12/19
04:41 pm
srpt
Form 4 Sarepta Therapeutics, For: Dec 18 Filed by: Chambers Michael Andrew
Low
Report
Form 4 Sarepta Therapeutics, For: Dec 18 Filed by: Chambers Michael Andrew
12/19
04:35 pm
srpt
Form 8-K Sarepta Therapeutics, For: Dec 18
Low
Report
Form 8-K Sarepta Therapeutics, For: Dec 18
12/18
08:05 pm
srpt
Form 4 Sarepta Therapeutics, For: Dec 16 Filed by: Estepan Ian Michael
Medium
Report
Form 4 Sarepta Therapeutics, For: Dec 16 Filed by: Estepan Ian Michael
12/16
05:05 pm
srpt
Form 144 Sarepta Therapeutics, Filed by: Estepan Ian Michael
Medium
Report
Form 144 Sarepta Therapeutics, Filed by: Estepan Ian Michael
12/11
07:14 am
srpt
Form 8-K Sarepta Therapeutics, For: Dec 10
Low
Report
Form 8-K Sarepta Therapeutics, For: Dec 10
12/10
08:05 pm
srpt
Form 4 Sarepta Therapeutics, For: Dec 01 Filed by: Wong Ryan Ho-Yan
Low
Report
Form 4 Sarepta Therapeutics, For: Dec 01 Filed by: Wong Ryan Ho-Yan
12/9
08:30 pm
srpt
Form 4 Sarepta Therapeutics, For: Dec 07 Filed by: INGRAM DOUGLAS S
Low
Report
Form 4 Sarepta Therapeutics, For: Dec 07 Filed by: INGRAM DOUGLAS S
12/8
07:33 am
srpt
Form 8-K Sarepta Therapeutics, For: Dec 07
Low
Report
Form 8-K Sarepta Therapeutics, For: Dec 07
12/2
08:02 pm
srpt
Form 4 Sarepta Therapeutics, For: Nov 28 Filed by: Rothfuss Cristin
Medium
Report
Form 4 Sarepta Therapeutics, For: Nov 28 Filed by: Rothfuss Cristin
11/19
08:05 pm
srpt
Form 4 Sarepta Therapeutics, For: Nov 17 Filed by: Rodino-Klapac Louise
Low
Report
Form 4 Sarepta Therapeutics, For: Nov 17 Filed by: Rodino-Klapac Louise
11/14
04:11 pm
srpt
Form SCHEDULE 13G/A Sarepta Therapeutics, Filed by: D. E. SHAW & CO, L.P.
Medium
Report
Form SCHEDULE 13G/A Sarepta Therapeutics, Filed by: D. E. SHAW & CO, L.P.
11/10
08:55 am
srpt
Form SCHEDULE 13G Sarepta Therapeutics, Filed by: STATE STREET CORP
Medium
Report
Form SCHEDULE 13G Sarepta Therapeutics, Filed by: STATE STREET CORP
11/6
04:03 pm
srpt
Form 10-Q Sarepta Therapeutics, For: Sep 30
Low
Report
Form 10-Q Sarepta Therapeutics, For: Sep 30
11/3
04:18 pm
srpt
Form 8-K Sarepta Therapeutics, For: Nov 03
High
Report
Form 8-K Sarepta Therapeutics, For: Nov 03